STRS Ohio’s Jade Biosciences JBIO Stock Holding History

STRS Ohio’s Portfolio JBIO Stock Details JBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-900	Closed	-$13.9K	–	2134
2025 Q4	$13.9K	Hold	900	–	–	﹤0.01%	2124
2025 Q3	$7.77K	Sell	900 -4,000	-82%	-$32.7K	﹤0.01%	2165
2025 Q2	$49K	Buy	4,900 +4,837	+7,678%	+$165K	﹤0.01%	2028
2025 Q1	$5.52K	Hold	63	–	–	﹤0.01%	1894
2024 Q4	$5.83K	Hold	63	–	–	﹤0.01%	1859
2024 Q3	$4.6K	Hold	63	–	–	﹤0.01%	1951
2024 Q2	$3.65K	Hold	63	–	–	﹤0.01%	1940
2024 Q1	$65K	Sell	63 -3	-5%	-$2.29K	﹤0.01%	1740
2023 Q4	$52K	Hold	66	–	–	﹤0.01%	1768
2023 Q3	$31K	Hold	66	–	–	﹤0.01%	1847
2023 Q2	$39K	Hold	66	–	–	﹤0.01%	1833
2023 Q1	$46K	Hold	66	–	–	﹤0.01%	1795
2022 Q4	$67K	Hold	66	–	–	﹤0.01%	1778
2022 Q3	$38K	Hold	66	–	–	﹤0.01%	1863
2022 Q2	$35K	Hold	66	–	–	﹤0.01%	1909
2022 Q1	$42K	Hold	66	–	–	﹤0.01%	1964
2021 Q4	$27K	Hold	66	–	–	﹤0.01%	2081
2021 Q3	$48K	Buy	+66	New	+$36.9K	﹤0.01%	2074

Other funds holding JBIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

STRS Ohio's JBIO Position: Q1 2026 in Review

STRS Ohio sold out of Jade Biosciences (JBIO) in Q1 2026, closing a stake of 900 shares — an estimated $13.9K sold.

STRS Ohio first reported a position in JBIO in Q3 2021 and held it in 18 quarters. The position peaked at $67K in Q4 2022. 120 funds tracked by Wall St. Rank hold JBIO as of Q1 2026.

STRS Ohio reported no remaining Jade Biosciences position as of Q1 2026 after selling out during the quarter.
STRS Ohio sold 900 Jade Biosciences shares in Q1 2026, an estimated $13.9K.
STRS Ohio first reported a position in Jade Biosciences in Q3 2021 and held it in 18 quarters.
STRS Ohio's Jade Biosciences position peaked at $67K in Q4 2022.
120 funds tracked by Wall St. Rank held Jade Biosciences as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.